胎儿镜激光凝固术与期待治疗对I期双胎输血综合征的系统评价与Meta分析
该系统评价与Meta分析检索了PubMed、Web of Science和Scopus数据库(截至2022年3月1日),纳入5项研究,比较胎儿镜激光凝固术与期待治疗对无症状I期双胎输血综合征的结局。结果显示两组在至少一胎存活、单胎存活、双胎存活、分娩孕周、<32周早产及<32周未足月胎膜早破方面均无显著差异。
要点
- 5项研究纳入Meta分析,比较胎儿镜激光凝固术与期待治疗无症状I期双胎输血综合征。
- 至少一胎存活(OR=1.40,95%CI 0.26-7.43,P=0.70)等生存指标两组无显著差异。
- 分娩孕周、<32周早产及<32周未足月胎膜早破风险两组亦无显著差异。
核心结论
- 对于无宫颈缩短的无症状稳定I期双胎输血综合征患者,26周前常规行胎盘吻合血管胎儿镜激光凝固术与期待治疗相比不提供生存优势,不太可能获益。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Web of Science和Scopus数据库自建库至2022年3月1日,最终纳入5项研究。
主要发现
- 至少一胎存活:胎儿镜激光凝固术组与期待治疗组比较,OR=1.40(95%CI 0.26-7.43,P=0.70),无显著差异。
- 单胎存活:OR=0.87(95%CI 0.51-1.48,P=0.60);双胎存活:OR=1.63(95%CI 0.74-3.62,P=0.23),两组均无显著差异。
- 分娩孕周:均值差=1.19(95%CI -0.25-2.63,P=0.10);<32周早产:OR=0.88(95%CI 0.50-1.54,P=0.65);<32周未足月胎膜早破:OR=1.80(95%CI 0.41-7.98,P=0.44),两组均无显著差异。
临床怎么用
- 原文结论指出,对于无宫颈缩短的无症状稳定I期双胎输血综合征患者,26周前常规行胎盘吻合血管胎儿镜激光凝固术与期待治疗相比不提供生存优势,不太可能获益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To investigate the outcomes of asymptomatic stage I twin-to-twin transfusion syndrome (stage I TTTS) among patients treated with fetoscopic laser photocoagulation (FLP) versus expectant management. Databases such as PubMed, Web of Science and Scopus were systematically searched from inception up to March 1st, 2022. The primary outcome was at least one fetal survival at birth and secondary outcomes included gestational age at delivery, preterm premature rupture of membranes < 32 weeks, preterm birth < 32 weeks, and single and dual fetal survival. Five studies were included in the meta-analysis. There was no significant difference in terms of at least one survival (odds ratio (OR) = 1.40, 95%CI= (0.26, 7.43), P = 0.70), single survival (OR = 0.87, 95%CI= (0.51, 1.48), P = 0.60) and dual survival (OR = 1.63, 95%CI= (0.74, 3.62), P = 0.23) among FLP and expectant groups. Gestational age at delivery (mean difference = 1.19, 95%CI= (-0.25, 2.63), P = 0.10), the risk of PTB<32 weeks (OR = 0.88, 95%CI= (0.50, 1.54), P = 0.65), and pPROM<32 weeks (OR = 1.80, 95% CI= (0.41, 7.98), P = 0.44) were also comparable between the groups. Routine FLP of the placental anastomoses before 26 weeks of gestation is unlikely to be beneficial among asymptomatic stable stage I TTTS patients without cervical shortening as the procedure does not offer a survival advantage compared with expectant management.
引用
- Nassr AA, Hessami K, Zargarzadeh N, et al. Fetoscopic laser photocoagulation versus expectant management for stage I twin-to-twin transfusion syndrome: A systematic review and meta-analysis. Prenat Diagn. 2023. PMID: 37539833. doi:10.1002/pd.6413
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。